learn Tofacitinib
a JAK inhibitor for alopecia areata and other autoimmune conditions
Search
forLearn
5 / 34 resultslearn Overview
learn Alopecia Areata
autoimmune disorder causing patchy hair loss
learn Neem Oil
natural substance from Neem tree with medicinal and pesticidal properties
learn Platelet-Derived Growth Factor Beta Polypeptide
Research
5 / 1000+ results
research Clinical Utility and Validity of Minoxidil Response Testing in Androgenetic Alopecia
Minoxidil response testing helps treat hair loss effectively and safely.
research Clinical Response of Alopecia, Trichorrhexis Nodosa, and Dry, Scaly Skin to Zinc Supplementation
Zinc supplements improved hair and skin conditions in two patients.
research Clinical Response to Combined Therapy of Cyclosporine and Prednisone
Combined prednisone and cyclosporine therapy led to excellent hair regrowth and improved well-being.
research Clinical Response to Adjunctive Platelet-Rich Plasma Injections in a Patient with Alopecia Universalis on Oral Tofacitinib
A woman with severe hair loss saw significant hair regrowth after adding platelet-rich plasma injections to her treatment with tofacitinib.
research Impact of Clinical Response on Different Approved Doses in Japan and the United States
Different drug doses approved in Japan and the U.S. are not mainly due to different clinical responses, and ethnic factors should be considered in setting drug doses.
Community Join
5 / 1000+ resultscommunity Pelage Announces Positive Results of Phase 2a Trials for PP405
PP405 shows promise in treating severe hair loss, with 31% of users experiencing over 20% hair density increase in four weeks, faster than minoxidil and finasteride. Some users are skeptical about the results' significance and long-term efficacy.
community PP405 Phase 2a press release with early results
PP405 shows promise in hair regrowth, with 31% of participants experiencing over 20% increase in hair density after 8 weeks. Phase 3 trials are expected in 2026, with potential market availability by 2029-2031.
community Amplifica’s AMP-303 Study Unveils New Hope for Hair Loss Treatments
AMP-303, a new injectable treatment for androgenetic alopecia, showed promising results in increasing hair count and density with minimal side effects. The treatment demonstrated significant hair regrowth and durability, offering new hope for those with hair loss.
community COMPLETE OVERVIEW of the Treatment of androgenetic alopecia in men
Male androgenetic alopecia is commonly treated with topical minoxidil and oral finasteride, both requiring continuous use. Other options include hair restoration surgery, dutasteride, light therapy, and camouflaging agents.
community 18-month results of ~1.5mg fin/day, 0.5mg dut 3x/week, 5% topical minox daily, dermarolling 2x monthly, nizoral 2x weekly, vitamin supplements daily, and a healthier diet. 30 y/o M doctor, couldn't stand the idea of losing my bun. Long time lurker, how'd I do?
The conclusion of the conversation is that the user, "Hello_Knicks," achieved significant hair growth and density by consistently using a combination of finasteride, dutasteride, minoxidil, dermarolling, nizoral, vitamin supplements, and a healthier diet. The user, who is a medical doctor, believes that patience, persistence, and medication compliance are key factors in achieving positive results.